Abstract |
Four new diam(m)ine platinum complexes containing the dichloroacetate moiety in 3-dichoroacetoxylcyclobutane-1,1-dicarboxylate as the leaving group were synthesized, characterized by elemental analysis as well as by ESI(+)-MS (electrospray ionization mass spectrometry in positive mode), FT-IR, (1)H- and (13)C-NMR, and evaluated for their in vitro anticancer activity against human lung cancer cell line (A549) and ovarian cancer cell lines (SK-OV-3, SK-OV-3/DDP). Diam(m)ines used in the present study belong to the carriers of six clinically approved platinum drugs. Among the complexes synthesized, complex 2, cis-[Pt(II)(1R,2R-diaminocyclohexane)·(3-dichoroacetoxylcyclobutane-1,1-dicarboxylate)] is the most promising in terms of water solubility and potential of being totally devoid of cross-drug resistance with cisplatin. Therefore, complex 2 was selected for the dichloroacetate release test. The test shows dichloroacetate can be efficiently released from complex 2 under physiological conditions via the hydrolysis of an ester bond bridging the dichloroacetate moiety and platinum pharmacophores together. Our study supports the further evaluation of this complex as a drug candidate.
|
Authors | Weiping Liu, Jing Jiang, Yongping Xu, Shuqian Hou, Liping Sun, Qingsong Ye, Liguang Lou |
Journal | Journal of inorganic biochemistry
(J Inorg Biochem)
Vol. 146
Pg. 14-8
(May 2015)
ISSN: 1873-3344 [Electronic] United States |
PMID | 25706321
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Organoplatinum Compounds
- Dichloroacetic Acid
|
Topics |
- Antineoplastic Agents
(chemical synthesis, pharmacology)
- Apoptosis
(drug effects)
- Cell Line, Tumor
- Dichloroacetic Acid
(chemistry, pharmacology)
- Humans
- Organoplatinum Compounds
(chemical synthesis, pharmacology)
|